These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 16234183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis.
    Brunner J, Sitzmann FC.
    Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
    Spârchez M, Miu N, Bolba C, Iancu M, Spârchez Z, Rednic S.
    Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
    [Abstract] [Full Text] [Related]

  • 6. Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
    Gupta R, Thabah MM, Vaidya B, Gupta S, Lodha R, Kabra SK.
    Indian J Pediatr; 2010 Jan; 77(1):41-4. PubMed ID: 20135267
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.
    Pang SY, Liu HY, Huang YJ, Liu YF, Dai YM, Zeng P, Zeng HS.
    Genet Mol Res; 2016 May 13; 15(2):. PubMed ID: 27323035
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
    Moore TL, Gillian BE, Crespo-Pagnussat S, Feller L, Chauhan AK.
    Clin Exp Rheumatol; 2014 May 13; 32(5):740-6. PubMed ID: 25068682
    [Abstract] [Full Text] [Related]

  • 11. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ.
    Arthritis Rheum; 2000 Jan 13; 43(1):155-63. PubMed ID: 10643712
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.
    J Rheumatol; 2006 Dec 13; 33(12):2390-7. PubMed ID: 16924694
    [Abstract] [Full Text] [Related]

  • 15. Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).
    Berntson L, Nordal E, Fasth A, Aalto K, Herlin T, Nielsen S, Rygg M, Zak M, Rönnelid J, Nordic Study Group of Pediatric Rheumatology (NoSPeR).
    Pediatr Rheumatol Online J; 2014 Dec 13; 12():22. PubMed ID: 24944545
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.